Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Anticuerpos Bispecíficos

Research Grade Cevostamab (HV698016)

Research Grade Cevostamab
Research Grade Cevostamab
Research Grade Cevostamab
Research Grade Cevostamab
Precio(USD): $
Especificación:
  • 100ug
  • 1mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

Vista general
Número de catálogoHV698016
Descripción
Cevostamab (HV698016) is a research-grade recombinant antibody targeting CD307. Produced in mammalian cells with native-like glycosylation.
Highlights
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especiesHuman
AplicacionesELISA, Bioactivity: FACS, Functional assay, Research in vivo
Especie huéspedHumanized
IsotipoIgG1-kappa
Sistema de expresión Mammalian Cells
Clonalidad Monoclonal
Objetivo FcRL5, FCRH5, FCRL5, Fc receptor homolog 5, FcRH5, CD307e, FcR-like protein 5, IRTA2, Immune receptor translocation-associated protein 2, BXMAS1, Fc receptor-like protein 5, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Nivel de endotoxinas Please contact the lab for this information.
Pureza >95% purity as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso Q96RD9 & P07766
Forma Liquid
Buffer de almacenamiento 0.01M PBS, pH 7.4.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Nombres alternativosBispecific, BFCR-4350-A, BFCR-4350A, RG-6160, RO-7187797, 2249888-53-5
FondoCevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells.
Nota For research use only. Not suitable for clinical or therapeutic use.
Imágenes
  • Research Grade Cevostamab

    SDS-PAGE

    SDS-PAGE for Research Grade Cevostamab.

  • Research Grade Cevostamab

    Bioactivity

    SEC-HPLC detection for Research Grade Cevostamab.

Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: support@abinScience.com

Lista de distribuidores